Christopher Guttman-McCabe, serving as the Chief Regulatory & Communications Officer for Anterix Inc. (NASDAQ: ATEX), has filed disclosures detailing substantial equity transactions on June 15, 2026. The executive's reported activity involves a significant divestment of common stock alongside a concurrent acquisition of shares through option exercises. Specifically, Mr. Guttman-McCabe sold common stock with a total value of approximately $7,539,883. In a parallel transaction, he acquired shares through stock option exercises valued at roughly $4,604,055.
The executive disposed of a total of 91,437 shares of Anterix common stock. These sales were executed at prices ranging between $81.32 and $84.29 per share. The timing of these divestments is notable given the stock's recent performance. ATEX has surged 262% year-to-date and is currently trading near its 52-week high of $88.12. According to InvestingPro analysis, ATEX may appear overvalued at these current levels, with the stock exhibiting overbought conditions. This assessment is one of 14 key ProTips available to subscribers.
Concurrently with the sales, Mr. Guttman-McCabe acquired 122,852 shares of Anterix common stock by exercising stock options. These acquisitions were made at exercise prices ranging from $25.75 to $49.39 per share. All exercised options were fully vested at the time of the transaction. The reported prices for the sales represent weighted averages, with actual transaction prices falling within specified ranges for each block of shares sold.
Following these transactions, Mr. Guttman-McCabe directly holds 77,807 shares of Anterix common stock. This position reflects the net effect of the recent sales and option exercises.
In broader corporate news, Anterix Inc. recently reported its fiscal fourth-quarter 2026 earnings, surpassing Wall Street expectations. The company achieved earnings of $0.98 per share, outperforming the anticipated loss of $0.54 per share. Revenue for the quarter reached $1.96 million, exceeding estimates of $1.47 million. These results were bolstered by spectrum monetization, stronger cash collection, and early success in new products. Analysts had projected lower figures, making this outcome notable. The company’s financial performance has been a focal point for investors, particularly given the unexpected profitability. These recent developments highlight Anterix’s positive trajectory in its financial operations.